Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Opioid-Induced Constipation (OIC) - Overview
Opioid-Induced Constipation (OIC) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Opioid-Induced Constipation (OIC) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Opioid-Induced Constipation (OIC) - Companies Involved in Therapeutics Development
Algobate AG
Bausch Health Companies Inc
Mallinckrodt Plc
Shionogi & Co Ltd
Opioid-Induced Constipation (OIC) - Drug Profiles
dolcatide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lubiprostone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ldemedine tosylate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
loxone hydrochloride PR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize Mu Opioid Receptor for Drug Abuse, Alcohol Addiction and OIC - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Opioid-Induced Constipation (OIC) - Dormant Projects
Opioid-Induced Constipation (OIC) - Discontinued Products
Opioid-Induced Constipation (OIC) - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development for Opioid-Induced Constipation (OIC), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development for Opioid-Induced Constipation (OIC), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Opioid-Induced Constipation (OIC) - Pipeline by Algobate AG, H1 2020
Opioid-Induced Constipation (OIC) - Pipeline by Bausch Health Companies Inc, H1 2020
Opioid-Induced Constipation (OIC) - Pipeline by Mallinckrodt Plc, H1 2020
Opioid-Induced Constipation (OIC) - Pipeline by Shionogi & Co Ltd, H1 2020
Opioid-Induced Constipation (OIC) - Dormant Projects, H1 2020
Opioid-Induced Constipation (OIC) - Discontinued Products, H1 2020